| Recent advances in protein and peptide drug delivery: a special emphasis on polymeric nanoparticles A Patel, M Patel, X Yang, A K. Mitra Protein and peptide letters 21 (11), 1102-1120, 2014 | 215 | 2014 |
| Importance of hepatic transporters in clinical disposition of drugs and their metabolites M Patel, KS Taskar, MJ Zamek‐Gliszczynski The Journal of Clinical Pharmacology 56, S23-S39, 2016 | 118 | 2016 |
| Clinically relevant drug–drug interactions between antiretrovirals and antifungals RK Vadlapatla, M Patel, DK Paturi, D Pal, AK Mitra Expert opinion on drug metabolism & toxicology 10 (4), 561-580, 2014 | 67 | 2014 |
| Intestinal P‐gp and putative hepatic OATP1B induction: international transporter consortium perspective on drug development implications MJ Zamek‐Gliszczynski, M Patel, X Yang, JD Lutz, X Chu, KLR Brouwer, ... Clinical Pharmacology & Therapeutics 109 (1), 55-64, 2021 | 48 | 2021 |
| Molecular expression and functional activity of sodium dependent multivitamin transporter in human prostate cancer cells M Patel, RK Vadlapatla, S Shah, AK Mitra International journal of pharmaceutics 436 (1-2), 324-331, 2012 | 47 | 2012 |
| Targeting SVCT for enhanced drug absorption: synthesis and in vitro evaluation of a novel vitamin C conjugated prodrug of saquinavir S Luo, Z Wang, M Patel, V Khurana, X Zhu, D Pal, AK Mitra International journal of pharmaceutics 414 (1-2), 77-85, 2011 | 46 | 2011 |
| Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma SM Cheal, H Xu, H Guo, M Patel, B Punzalan, EK Fung, S Lee, M Bell, ... Theranostics 8 (18), 5106, 2018 | 42 | 2018 |
| Approaching the Shockley–Queisser limit for fill factors in lead–tin mixed perovskite photovoltaics K Jayawardena, RMI Bandara, M Monti, E Butler-Caddle, T Pichler, ... Journal of Materials Chemistry A 8 (2), 693-705, 2020 | 41 | 2020 |
| Alpha radioimmunotherapy using 225Ac-proteus-DOTA for solid tumors-safety at curative doses SM Cheal, MR McDevitt, BH Santich, M Patel, G Yang, EK Fung, ... Theranostics 10 (25), 11359, 2020 | 39 | 2020 |
| Molecular and functional characterization of riboflavin specific transport system in rat brain capillary endothelial cells M Patel, RK Vadlapatla, D Pal, AK Mitra Brain research 1468, 1-10, 2012 | 35 | 2012 |
| A self-assembling and disassembling (SADA) bispecific antibody (BsAb) platform for curative two-step pretargeted radioimmunotherapy BH Santich, SM Cheal, M Ahmed, MR McDevitt, O Ouerfelli, G Yang, ... Clinical Cancer Research 27 (2), 532-541, 2021 | 34 | 2021 |
| Functional characterization and molecular expression of large neutral amino acid transporter (LAT1) in human prostate cancer cells M Patel, P Dalvi, M Gokulgandhi, S Kesh, T Kohli, D Pal, AK Mitra International journal of pharmaceutics 443 (1-2), 245-253, 2013 | 31 | 2013 |
| Design of lipophilic prodrugs to improve drug delivery and efficacy A Mandal, M Patel, Y Sheng, A K Mitra Current drug targets 17 (15), 1773-1798, 2016 | 30 | 2016 |
| Amino acid prodrugs: an approach to improve the absorption of HIV-1 protease inhibitor, lopinavir M Patel, N Mandava, M Gokulgandhi, D Pal, AK Mitra Pharmaceuticals 7 (4), 433-452, 2014 | 28 | 2014 |
| Clinical relevance of hepatic and renal P‐gp/BCRP inhibition of drugs: An international transporter consortium perspective KS Taskar, X Yang, S Neuhoff, M Patel, K Yoshida, MF Paine, ... Clinical Pharmacology & Therapeutics 112 (3), 573-592, 2022 | 26 | 2022 |
| An N-Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy SM Cheal, M Patel, G Yang, D Veach, H Xu, H Guo, PB Zanzonico, ... Bioconjugate chemistry 31 (3), 501-506, 2019 | 24 | 2019 |
| Amino acid prodrug of quinidine: an approach to circumvent P-glycoprotein mediated cellular efflux M Patel, NK Mandava, D Pal, AK Mitra International journal of pharmaceutics 464 (1-2), 196-204, 2014 | 21 | 2014 |
| Ocular transporters and receptors: their role in drug delivery AK Mitra Elsevier, 2013 | 19 | 2013 |
| Efficacy of HER2-targeted intraperitoneal 225Ac α-pretargeted radioimmunotherapy for small-volume ovarian peritoneal carcinomatosis SK Chung, DB Vargas, CS Chandler, S Katugampola, DR Veach, ... Journal of Nuclear Medicine 64 (9), 1439-1445, 2023 | 14 | 2023 |
| Intraperitoneal pretargeted radioimmunotherapy for colorectal peritoneal carcinomatosis CS Chandler, MM Bell, SK Chung, DR Veach, EK Fung, B Punzalan, ... Molecular cancer therapeutics 21 (1), 125-137, 2022 | 14 | 2022 |
